wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40077818-06B43181-AE8B-4DF1-A5C6-0C9E265154D7
Q40077818-06B43181-AE8B-4DF1-A5C6-0C9E265154D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40077818-06B43181-AE8B-4DF1-A5C6-0C9E265154D7
Current progress in innovative engineered antibodies.
P2860
Q40077818-06B43181-AE8B-4DF1-A5C6-0C9E265154D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40077818-06B43181-AE8B-4DF1-A5C6-0C9E265154D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfc833b247e190f1dbabc0b0f3c64597faeeebb7
P2860
Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.